These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3535601)

  • 21. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin and heparinoids in stroke.
    Sherman DG
    Neurology; 1998 Sep; 51(3 Suppl 3):S56-8. PubMed ID: 9744837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention. A population-based study.
    Petty GW; Brown RD; Whisnant JP; Sicks JD; O'Fallon WM; Wiebers DO
    Ann Intern Med; 1999 Jan; 130(1):14-22. PubMed ID: 9890845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.
    Telford AM; Wilson C
    Lancet; 1981 Jun; 1(8232):1225-8. PubMed ID: 6112564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.
    Hull RD; Raskob GE; Hirsh J; Jay RM; Leclerc JR; Geerts WH; Rosenbloom D; Sackett DL; Anderson C; Harrison L
    N Engl J Med; 1986 Oct; 315(18):1109-14. PubMed ID: 3531862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin in the treatment of acute stroke.
    Korczyn AD
    Neurol Clin; 1992 Feb; 10(1):209-17. PubMed ID: 1557003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke.
    McCarthy ST; Turner J
    Age Ageing; 1986 Mar; 15(2):84-8. PubMed ID: 3962762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Low molecular weight heparin: immediate therapy of stroke? A discussion of the study by Kay et al.: Low molecular weight heparin for treatment of acute ischemic stroke].
    Sporer B; Haberl RL
    Nervenarzt; 1996 Oct; 67(10):886-7. PubMed ID: 9036364
    [No Abstract]   [Full Text] [Related]  

  • 30. Stroke. The use and overuse of heparin in therapeutic trials.
    Sage JI
    Arch Neurol; 1985 Apr; 42(4):315-7. PubMed ID: 3885920
    [No Abstract]   [Full Text] [Related]  

  • 31. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone in acute stroke.
    Mulley G; Wilcox RG; Mitchell JR
    Br Med J; 1978 Oct; 2(6143):994-6. PubMed ID: 361156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial.
    Walker MG; Shaw JW; Thomson GJ; Cumming JG; Thomas ML
    Br Med J (Clin Res Ed); 1987 May; 294(6581):1189-92. PubMed ID: 3109574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
    Büller HR; Davidson BL; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob G; van den Berg-Segers AE; Cariou R; Leeuwenkamp O; Lensing AW;
    N Engl J Med; 2003 Oct; 349(18):1695-702. PubMed ID: 14585937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of naloxone on acute stroke.
    Czlonkowska A; Cyrta B
    Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
    Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Magnani HN; Hull RD; Gent M
    Lancet; 1987 Mar; 1(8532):523-6. PubMed ID: 2434815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural history of progressive ischemic stroke in a population treated with heparin.
    Slivka A; Levy D
    Stroke; 1990 Dec; 21(12):1657-62. PubMed ID: 2264071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
    De Reuck J; Van Vleymen B
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():33-7. PubMed ID: 10338106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new technique in the treatment of thromboembolic stroke Preliminary Report.
    Leon-Sotomayor L
    Angiology; 1980 Nov; 31(11):729-43. PubMed ID: 6161569
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.